Tagaylo, Jea .

HRN: 23-47-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2023
CEFUROXIME 1.5GM (VIAL)
09/16/2023
09/17/2023
IV
1.5gm
Q8 X 2 More Doses
Post OP Prophylaxis
Waiting Final Action 
09/16/2023
CEFUROXIME 1.5GM (VIAL)
09/16/2023
09/17/2023
IV
1.5 G X 2 Doses
Q8
Sp Rpeat LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: